Brimble; Margaret Anne
Patent Applications and Registrations
Patent applications and USPTO patent grants for Brimble; Margaret Anne.The latest application filed is for "nitrification inhibitors".
Company Profile
12.23.28
- Brimble; Margaret Anne - Hamilton NZ
- Brimble; Margaret Anne - Auckland NZ
- BRIMBLE; Margaret Anne - Epsom Auckland
Patent Activity
| Patent | Date |
|---|---|
| Nitrification Inhibitors App 20220153655 - Podolyan; Andriy ; et al. | 2022-05-19 |
| Carbon monoxide releasing norbornenone compounds Grant 11,072,584 - Sammut , et al. July 27, 2 | 2021-07-27 |
| Amino acid and peptide conjugates and uses thereof Grant 11,014,960 - Brimble , et al. May 25, 2 | 2021-05-25 |
| Quinoline Sulfonamide Compounds and Their Use as Antibacterial Agents App 20200385354 - BRIMBLE; Margaret Anne ; et al. | 2020-12-10 |
| Peptide Conjugates, Conjugation Process, and Uses Thereof App 20200361864 - Brimble; Margaret Anne ; et al. | 2020-11-19 |
| Peptide Conjugate Cgrp Receptor Antagonists And Methods Of Preparation And Uses Thereof App 20200353088 - Harris; Paul William Richard ; et al. | 2020-11-12 |
| Amino Acid And Peptide Conjugates And Conjugation Process App 20200306370 - Brimble; Margaret Anne ; et al. | 2020-10-01 |
| Carbon Monoxide Releasing Norbornenone Compounds App 20200109115 - SAMMUT; Ivan Andrew ; et al. | 2020-04-09 |
| Amino acid and peptide conjugates and conjugation process Grant 10,576,144 - Brimble , et al. | 2020-03-03 |
| Carbon monoxide releasing norbornenone compounds Grant 10,494,344 - Sammut , et al. De | 2019-12-03 |
| Amino Acid and Peptide Conjugates and Uses Thereof App 20190256552 - Brimble; Margaret Anne ; et al. | 2019-08-22 |
| Amino acid and peptide conjugates and uses thereof Grant 10,253,062 - Brimble , et al. | 2019-04-09 |
| Amino Acid and Peptide Conjugates and Conjugation Process App 20190046636 - Brimble; Margaret Anne ; et al. | 2019-02-14 |
| Carbon Monoxide Releasing Norbornenone Compounds App 20180346420 - SAMMUT; Ivan Andrew ; et al. | 2018-12-06 |
| Amino Acid and Peptide Conjugates and Uses Thereof App 20180002373 - Brimble; Margaret Anne ; et al. | 2018-01-04 |
| Synthetic Analogues Of Neural Regeneration Peptides App 20170218023 - Harris; Paul William Richard ; et al. | 2017-08-03 |
| Synthetic analogues of neural regeneration peptides Grant 9,650,418 - Harris , et al. May 16, 2 | 2017-05-16 |
| Amino Acid And Peptide Conjugates And Conjugation Process App 20170095554 - BRIMBLE; Margaret Anne ; et al. | 2017-04-06 |
| Rodenticidal norbormide analogues Grant 9,198,420 - Hopkins , et al. December 1, 2 | 2015-12-01 |
| Rodenticidal Norbormide Analogues App 20150025113 - Hopkins; Brian ; et al. | 2015-01-22 |
| Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid Grant 8,637,567 - Gluckman , et al. January 28, 2 | 2014-01-28 |
| Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy Grant 8,519,127 - Bickerdike , et al. August 27, 2 | 2013-08-27 |
| Synthetic analogues of neural regeneration peptides Grant 8,309,684 - Harris , et al. November 13, 2 | 2012-11-13 |
| Neural regeneration peptides and formulations thereof Grant 8,138,304 - Sieg , et al. March 20, 2 | 2012-03-20 |
| Neuroprotective bicyclic compounds and methods for their use Grant 8,067,425 - Brimble , et al. November 29, 2 | 2011-11-29 |
| Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage Grant 8,013,170 - Harris , et al. September 6, 2 | 2011-09-06 |
| Cognitive Enhancement And Cognitive Therapy Using Glycyl-l-2-methylprolyl-l-glutamic Acid App 20110112033 - Gluckman; Peter David ; et al. | 2011-05-12 |
| Synthetic Analogues Of Neural Regeneration Peptides App 20110098228 - Harris; Paul William Richard ; et al. | 2011-04-28 |
| Cyclic Glycyl-2-allyl Proline And Its Use In Treatment Of Peripheral Neuropathy App 20110052531 - Bickerdike; Mike John ; et al. | 2011-03-03 |
| Neuroprotective macrocyclic compounds and methods for their use App 20110052528 - Harris; Paul William Richard ; et al. | 2011-03-03 |
| Analogs of glycyl-prolyl-glutamate Grant 7,863,304 - Brimble , et al. January 4, 2 | 2011-01-04 |
| Cyclic G-2Allylproline in treatment of Parkinson's disease Grant 7,776,876 - Brimble , et al. August 17, 2 | 2010-08-17 |
| Neural regeneration peptides and methods for their use App 20100130410 - Sieg; Frank ; et al. | 2010-05-27 |
| Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate Grant 7,714,020 - Gluckman , et al. May 11, 2 | 2010-05-11 |
| Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration Grant 7,605,177 - Gluckman , et al. October 20, 2 | 2009-10-20 |
| Neuroprotective macrocyclic compounds and methods for their use Grant 7,485,630 - Harris , et al. February 3, 2 | 2009-02-03 |
| Analogs of Glycyl-Prolyl-Glutamate App 20080145335 - Brimble; Margaret Anne ; et al. | 2008-06-19 |
| Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration App 20070298009 - Gluckman; Peter David ; et al. | 2007-12-27 |
| Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate App 20070004641 - Gluckman; Peter David ; et al. | 2007-01-04 |
| Cyclic G-2AllylProline in treatment of Parkinson's disease App 20060258663 - Brimble; Margaret Anne ; et al. | 2006-11-16 |
| Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate App 20060251649 - Gluckman; Peter David ; et al. | 2006-11-09 |
| Neuroprotective macrocyclic compounds and methods for their use App 20060217295 - Harris; Paul William Richard ; et al. | 2006-09-28 |
| GPE analogs and peptidominetics Grant 7,041,314 - Abood , et al. May 9, 2 | 2006-05-09 |
| GPE analogs and peptidominetics App 20030055004 - Abood, Norman A. ; et al. | 2003-03-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 